Evidence map›Paper›PMID 26578538›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.

Amalia S Magaret, Andrew Mujugira, James P Hughes, Jairam Lingappa, Elizabeth A Bukusi, Guy DeBruyn, Sinead Delany-Moretlwe, Kenneth H Fife, Glenda E Gray, Saidi Kapiga and 9 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021
    Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Sexually Transmitted Infections in People with Human Immunodeficiency Virus.Infectious disease clinics of North America · 2024
    Review
  11. Article
  12. Article
  13. Viral Venereal Diseases of the Skin.American journal of clinical dermatology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 8 countries.

Amalia S MagaretDepartment of Laboratory Medicine Department of Biostatistics Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Andrew MujugiraDepartment of Global Health Department of Epidemiology, University of Washington.
James P HughesDepartment of Biostatistics Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Jairam LingappaDepartment of Global Health Department of Pediatrics Department of Medicine, University of Washington, Seattle.
Elizabeth A BukusiCenter for Microbiology Research, Kenya Medical Research Institute (KEMRI), Nairobi.
Guy DeBruynSanofi Pasteur, Swiftwater, Pennsylvania.
Sinead Delany-MoretlweWits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Kenneth H FifeDepartment of Medicine, Indiana University, Indianapolis.
Glenda E GrayPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Saidi KapigaLondon School of Hygiene and Tropical Medicine, United Kingdom.
Etienne KaritaRwanda-Zambia HIV Research Group, Kigali, Rwanda, Lusaka, Zambia.
Nelly R MugoCenter for Microbiology Research, Kenya Medical Research Institute (KEMRI), Nairobi.
Helen ReesWits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Allan RonaldDepartment of Medicine, University of Manitoba, Winnipeg, Canada Infectious Disease Institute, Makerere University, Kampala, Uganda.
Bellington VwalikaRwanda-Zambia HIV Research Group, Kigali, Rwanda, Lusaka, Zambia Department of Obstetrics and Gynaecology, University of Zambia, School of Medicine, Lusaka.
Edwin WereDepartment of Reproductive Health, Moi University, Eldoret, Kenya.
Connie CelumDepartment of Global Health Department of Epidemiology, University of Washington, Department of Medicine, University of Washington, Seattle.
Anna WaldDepartment of Laboratory Medicine Department of Epidemiology, University of Washington, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Department of Medicine, University of Washington, Seattle.
Partners in Prevention HSV/HIV Transmission Study Team
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAKenya Medical Research Institute · KEUniversity of the Witwatersrand · ZAUniversity of Washington · USMoi University · KEUniversity of Manitoba · CAUniversity of Zambia · ZMIndiana University – Purdue University Indianapolis · USRwanda Zambia HIV Research Group · RWUniversity of London · GBSanofi (United States) · US

Funding

Soweto Clinical Trials UnitUM1AI069453 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI Glenda E Gray, Lerato Mohapi · 2012 to 2026
$40.9M
THE PERINATAL COMPLICATIONS OF ASYMPTOMATIC GENITAL HERPES SIMPLEX VIRUSP01AI030731 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, JIA · 1991 to 2017
$34.3M
Viral Determinants of HIV-1 Transmission in African HeterosexualsP01AI057005 · NIAID · UNIVERSITY OF WASHINGTON · PI COREY, LAWRENCE · 2003 to 2014
$20.5M
Medical Research Council G0901756NIAID NIH HHS AI-030731NIAID NIH HHS P01 AI030731NIAID NIH HHS P01 AI057005NIAID NIH HHS UM1 AI069453
6 · The paper itself

Abstract

backgroundThe efficacy of condoms for protection against transmission of herpes simplex virus type 2 (HSV-2) has been examined in a variety of populations with different effect measures. Often the efficacy has been assessed as change in hazard of transmission with consistent vs inconsistent use, independent of the number of acts. Condom efficacy has not previously measured on a per-act basis.

methodsWe examined the per-act HSV-2 transmission rates with and without condom use among 911 African HSV-2 and human immunodeficiency virus type 1 (HIV-1) serodiscordant couples followed for an average of 18 months in an HIV prevention study. Infectivity models were used to associate the log10 probability of HSV-2 transmission over monthly risk periods with reported numbers of protected and unprotected sex acts. Condom efficacy was computed as the proportionate reduction in transmission risk for protected relative to unprotected sex acts.

resultsTransmission of HSV-2 occurred in 68 couples, including 17 with susceptible women and 51 with susceptible men. The highest rate of transmission was from men to women: 28.5 transmissions per 1000 unprotected sex acts. We found that condoms were differentially protective against HSV-2 transmission by sex; condom use reduced per-act risk of transmission from men to women by 96% (P < .001) and marginally from women to men by 65% (P = .060).

conclusionsCondoms are recommended as an effective preventive method for heterosexual transmission of HSV-2.

Indexed as

CondomsDisease Transmission, InfectiousHerpes GenitalisHerpesvirus 2, HumanHIV InfectionsInfection ControlFamily CharacteristicsFemaleHumansMaleRisk AssessmentcondomefficacyHIVHSV-2transmission

Identifiers

PMID26578538
PMCPMC4725379
OpenAlexW2205645239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.